Vitamin C (HS 293627) Trade Flows (China to Algeria)
2025-07-09
 374 Visitors

This intelligence report provides a macro-analytical overview of the trade corridor for Vitamin C and its derivatives (HS 293627) between China and Algeria. As global supply chains for pharmaceutical-grade precursors and nutritional additives face increasing regulatory scrutiny, understanding the logistical and fiscal landscape of this specific trade lane is essential for procurement architects and supply chain managers.

Market Dynamics & Trade Volume

Annual Trade Performance

The trade of Vitamin C (HS 293627) remains a critical component of Algeria’s pharmaceutical and food-fortification import portfolio. China currently maintains its position as the dominant global exporter for this commodity, with total global export values for this category reaching approximately $653 million annually. Algeria’s specific import volume from China is characterized by consistent demand for unmixed, synthetic-grade ascorbic acid, driven by the local pharmaceutical manufacturing sector.

Sourcing Matrix: Key Metrics

Performance Indicators

Metric Estimated Value / Status
Estimated Annual Trade Volume (Global) ~$653 Million (Export Value)
Year-on-Year Growth Variable (Market-Dependent)
Supplier Market Share (China) Dominant (>60% of global supply)
Average Customs Clearance Window 15–30+ Working Days

Operational Logistics

Customs & Regulatory Hurdles

Importing into Algeria requires strict adherence to documentation protocols. The customs process is intensive, often requiring bank domiciliation, certificates of conformity, and quality assurance from independent third parties. Delays are frequently attributed to bureaucratic documentation requirements and the mandatory "Visa Fraud" inspection process for specific imports.

Sourcing Advisory

Strategic Operational Memo

Operational Tip: Given the volatility in customs clearance times, which can extend beyond 30 days depending on documentation accuracy, it is highly recommended to utilize a local customs broker with specific expertise in pharmaceutical and chemical imports. Ensure all certificates of conformity are pre-validated by Algerian authorities to avoid port-side storage fees and potential cargo abandonment.

Market Outlook

Future Strategic Shifts

The reliance on Chinese supply for HS 293627 is expected to persist, though Algeria is increasingly focusing on diversifying its pharmaceutical supply chain. Future shifts may include increased local production of finished goods, which could pivot import demand from raw Vitamin C powder to more specialized, high-value derivatives.

References

Author
Roy Simmons